Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
      
 
 

Southwestern Clinical Pharmacy Seminar 2018


April 27-29, 2018
Marriott Tucson University Park Hotel
           CLICK THE IMAGE ABOVE TO VIEW THE FULL CONFERENCE AGENDA
 

 

HOTEL ACCOMMODATIONS: 

Marriott Tucson University Park Hotel

880 E 2nd St

Tucson, AZ 85719

520-792-4100

 

 The Arizona Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing education. 

 

 

Date: Apr 28, 2018 08:00 AM - Apr 29, 2018 12:00 PM

Location: Tucson University Park Hotel, 880 E 2nd St, Tucson , Az, 85719

CE Hours

16.50

CE Units

1.650

Registration closes on Apr 30, 2018 05:00 PM

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians
  • Student

Accreditation(s)

Accreditation Council for Pharmacy Education
The Arizona Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as providers of continuing education.

Please choose a Fee Type from the Drop Down Menu Below:
I am a
 

 

Registration closes on Apr 30, 2018 at 05:00 PM

Registration Closed  

Current Issues in Acute and Ambulatory Pharmacy Practice:  A National Perspective
 
Pharmacist learning objectives:
At the completion of this activity, the participant will be able to:
1.  Describe the pharmacy profession's efforts in pursuing provider status at the national level, what impact this has on state level, and what can be done to prepare.
2.  Discuss the impact of drug shortages on patient care and ASHP's efforts in dealing with drug shortages.
3.  Describe the current opioid crisis in the US. and ASHP's efforts in assisting in this national crisis.
4.  Discuss ways the pharmacy profession can progress and adapt to advance its patient care contributions by implementation of the Practice Advancement Initiative (PAI) and its strategic planning tools.
5.  Describe the impact of clinician burnout on patient care as it relates to the healthcare workforce and share strategies and next steps to lessen stress among pharmacy and other healthcare professionals.
 
Pharmacy Technician learning objectives:
At the completion of this activity, the participant will be able to:
1.  Describe the pharmacy profession's efforts in pursuing provider status at the national level, what impact this has on state level, and what can be done to prepare.
2.  Discuss the impact of drug shortages on patient care and ASHP's efforts in dealing with drug shortages.
3.  Describe the current opioid crisis in the US. and ASHP's efforts in assisting in this national crisis.
4.  Discuss ways the pharmacy profession can progress and adapt to advance its patient care contributions by implementation of the Practice Advancement Initiative (PAI) and its strategic planning tools.
5.  Describe the impact of clinician burnout on patient care as it relates to the healthcare workforce and share strategies and next steps to lessen stress among pharmacy and other healthcare professionals.

Speaker(s)/Author(s)

Julie L. Webb picture

Julie L. Webb, BS Pharm.
Senior VP, Office of Professional Development, ASHP


Brief Bio : Julie Webb has extensive experience in pharmacy practice, association management, and educational meeting planning. As Senior Vice President for ASHP’s Office of Professional Development, she oversees ASHP educational enterprise including the ASHP Midyear Clinical Meeting and ASHP’s Summer Meetings. In addition she is responsible for the exploration and implementation of products and services to support ASHP’s overall mission as a membership association. She oversees ASHP Advantage branded educational offerings, ASHP’s Certification Resources and Professional Certificate product lines, and ASHP’s eLearning platform. Prior to assuming the role of Senior Vice President, Julie served as the Vice President and Senior Managing Director for Resources Development and Senior Director of Business Development for ASHP Advantage where she was responsible for program development, promotion, and marketing activities. Julie has also served as the Director of the ASHP Section of Home Care Practitioners, a membership component group of the American Society of Health-System Pharmacists (ASHP). Julie's pharmacy practice experience includes home, acute care, and veterinary medicine. She has also served as a consultant to the home infusion industry. An alumnus of the School of Pharmacy at the University of North Carolina at Chapel Hill, Julie completed an ASHP-accredited residency in hospital pharmacy at the Medical University of South Carolina in Charleston.

Activity Number

0100-0000-17-069-L03-P
Date: 04/28/18
Time: 08:00 AM - 09:30 AM

CE Hours

1.50
Registration Closed  

Registration Closed  

Case Studies in Antimicrobial Stewardship Programs:  Challenges and Potential Solutions
 
Pharmacist learning objectives:
1.  Identify the measured goals and objectives of an antimicrobial stewardship program (ASP).
2.  Sell your ASP to hospital administration, medical staff, and your Pharmacy Director.
3.  Pace your ASP projects - discover, diagnose, design, and deliver.
4.  Identify potential solutions to several case-based clinical scenarios which may be barriers to the implementation and operation of ASPs.
5.  Apply real-world case scenarios to help overcome your challenges and barriers for your ASP.
 
Pharmacy Technician learning objectives:
1.  Work with Pharmcist staff in developing an alert system or portocol for specific antibiotics, regimens, duplication with or without the assistance of ASP software.
2.  Flag specific patients for potential antibiotic (and other drug) interventions, such as patients on hemodialysis or new patients in the ICU managed for sepsis.
3.  Identify agents with short stability times and communicate these new orders to the ASP.

Speaker(s)/Author(s)

Kimberly Halton Welker picture

Kimberly Halton Welker, PharmD., BCPS
Infectious Disease Pharmacist Specialist, Mercy Gilbert Medical Center


Brief Bio : Kimberly Halton Welker, PharmD is a clinical infectious disease pharmacist at Mercy Gilbert Medical Center (MGMC) in Gilbert, Arizona. She received her Doctor of Pharmacy Degree from Midwestern University College of Pharmacy- Glendale and completed an American Society of Health System Pharmacist accredited residency at Primary Children’s Medical Center (Intermountain Healthcare) in Salt Lake City, Utah. She completed an Infectious Disease specialty residency with the University of Houston College of Pharmacy and Cardinal Health in Houston, Texas. Kimberly accepted her current position at Mercy Gilbert in 2010. She is passionate about antimicrobial stewardship and medication safety.
Mark A. Redell picture

Mark A. Redell, BS, PharmD.
VP, Global Health Science Center, The Medicines Company


Brief Bio : Mark A. Redell, BS, PharmD. Antimicrobial stewardship has been a professional goal for 30 years, having worked as the Antimicrobial Stewardship Pharmacist for a 5-hospital system in Long Beach CA (1985 to 2000) and currently as Vice-President, Global Health Science Center at The Medicines Company. Innovative medical practices have been developed in this career, including the “Antibiogram Development Kit” for Johnson & Johnson and “What Every Health Care Executive Should Know: The Cost of Antibiotic Resistance” for Joint Commission Resources. In between moving stewardship forward, the work for the Arizona Department of Health Services as the Chair for the Antibiotic Stewardship Subcommittee has been rewarding. As a first-in-kind antimicrobial stewardship practice working for the Internal Medicine Department, the program demonstrated over 17,000 consultations with a 91% acceptance rate, passage of 12 practice guidelines, approval of a collaborative practices agreement, involvement in phase 3 drug trials, and mandatory examination of all medical staff in antimicrobial pharmacotherapy.

Vanthida Huang, PharmD., BSPHM, FCCP
Associate Professor, Midwestern University College of Pharmacy-Glendale


Brief Bio : Vanthida Huang, PharmD, BSPHM, FCCP, is an Associate Professor at Midwestern University College of Pharmacy-Glendale and Infectious Diseases Clinical Specialist at HonorHealth John C. Lincoln Medical Center. She is also has adjunct appointment as Associate Professor at the Midwestern College of Veterinary Medicine and Clinical Associate Professor at Mercer University School of Medicine. She received her BSPHM (1994) and PharmD (2001) from the Temple University School of Pharmacy. Prior to pursuing her PharmD, Dr. Huang was a clinical pharmacist at various hospitals including Pottstown Memorial Hospital, Milton S. Hershey Medical Center, and the University of Pennsylvania Hospital. After pursuing her PharmD, Dr. Huang completed an ASHP Accredited Pharmacy Practice Residency at Sarasota Memorial Hospital. She then completed a two-year fellowship in Infectious Diseases Pharmacotherapy at Wayne State University and Detroit Receiving Hospital. Following her fellowship she joined the faculty at Mercer University College of Pharmacy (MUCOP) for 10 years as an Assistant Professor and Associate Professor (with tenure) in Pharmacy Practice and Pharmaceutical Science Departments. Her areas of research include multidrug-resistant gram-positive bacteria; specifically methicillin-resistant Staphylococcus aureus (MRSA) in addition to antimicrobial pharmacodynamics and pharmacokinetics. Her research has been published in Antimicrobial Agents and Chemotherapy (AAC), International Journal of Antimicrobial Agents (IJAA), Journal of Antimicrobial Chemotherapy (JAC), and more. She received the MUCOP Excellence in Research Award in 2007, Society of Infectious Diseases Pharmacists (SIDP) Distinguished Service Award in 2015, and American College of Clinical Pharmacy (ACCP) IDPRN Distinguished Investigator in 2017. She serves on numerous committees at the College and University level, and within national organizations. She has served the SIDP as a chair, vice-chair, and member on the Research Awards Committee, Recognition Awards Committee, Election Committee, and Membership Committee. She also served the ACCP and IDPRN as chair, vice-chair, and member in several committees within the Society. She is also a member of the American Society for Microbiology (ASM), Infectious Diseases Society of America (IDSA), International Society of Anti-Infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and fellow of the American College of Clinical Pharmacy (ACCP).

Activity Number

0100-0000-17-066-L04-P/T
Date: 04/28/18
Time: 09:30 AM - 11:00 AM

CE Hours

1.50
Registration Closed  

Registration Closed  

Infectious Disease Therapy Updates
 
Pharmacist learning objectives:
At the completion of this activity, the participant will be able to: 
1.  Describe recently FDA approved anti-infective medications.
2.  Compare new agents with current available therapies.
3.  Describe circumstances inwhich recently approved therapies may be clinically indicated.
 
Pharmacy Technician learning objectives
At the completion of this activity, the participant will be able to: 
1.  Describe recently FDA approved anti-infective medications.
2.  Describe circumstances in which recently approved therapies may be clinically indicated.
 

Speaker(s)/Author(s)

Juan Villanueva picture

Juan Villanueva, PharmD, BCPS
Pharmacotherapy Specialist, Banner university Medical Center


Brief Bio : Juan Elias Villanueva attended the University of Texas at Austin College of Pharmacy where he earned his PharmD. He went on to complete a first year pharmacy residency with the University of Arizona/Banner University Medical Center Tucson and stayed on for a second year pharmacy residency in infectious diseases. He is currently a board certified pharmacotherapy specialist practicing as a clinical pharmacist at Banner University Medical Center, Tucson.

Activity Number

0100-0000-17-068-L01-P/T
Date: 04/28/18
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Let Your Voice be Heard:  A Discussion of Advocacy and ASHP House of Delegates Topics
 
Pharmacist learning objectives:
At the completion of this activity, the participant will be able to:
1.  Identify at least 2 methods of moving an idea for a pharmacy practice issue forward to the ASHP House of Delegates
2.  Discuss the role of Arizona delegates to the ASHP House of Delegates
3.  Discuss the potential impact of selected policies coming before the ASHP House of Delegates in June to the practice of pharmacy in Arizona and to pharmacy personnel.
 
Pharmacy Technician learning objectives:
At the completion of this activity, the participant will be able to:
1.  Identify at least 2 methods of moving an idea for a pharmacy practice issue forward to the ASHP House of Delegates
2.  Discuss the role of Arizona delegates to the ASHP House of Delegates
3.  Discuss the potential impact of selected policies coming before the ASHP House of Delegates in June to the practice of pharmacy in Arizona and to pharmacy personnel.

Speaker(s)/Author(s)

Carol Rollins picture

Carol Rollins, PharmD., BCNSP, FASHP, FAzPA
Clinical Professor/Clinical Pharmacist, University of Arizona College of Pharmacy


Brief Bio : Carol J. Rollins, M.S., Pharm.D., BCNSP, FAzPA, FASHP received her B.S. in Pharmacy and Pharm.D. from the University of Arizona. She completed a Nutrition Support Pharmacy Practice Residency at University Medical Center in Tucson, Arizona. Carol received her M.S. in Food Science and Nutrition from Purdue University, West Lafayette, Indiana, and her initial Bachelor’s degree from Concordia College, Moorhead, Minnesota. Rollins is currently the clinical pharmacist responsible for coordinating the nutrition support team at Banner University Medical Center Tucson and is Clinical Professor at the University of Arizona College of Pharmacy. She is Director of an ASHP accredited PGY2 Nutrition Support Pharmacy Residency and a preceptor for PGY1 and PGY2 residencies. Carol is an active member of the Health System Academy of AzPA and serves on several committees. She is one of the three Arizona representatives to the ASHP House of Delegates. Carol is also the Continuing Education Committee co-chair for AzPA 2017-2018.
Christi Jen  picture

Christi Jen , PharmD., BCPS
Emergency Medicine Pharmacists/PGY-1 Residency Director, Banner Boswell Medical Center


Brief Bio : Christi Jen, PharmD, BCPS is an Emergency Medicine Clinical Pharmacist and PGY1 Residency Program Director at Banner Boswell Medical Center in Sun City, Arizona. Dr. Jen is a board certified pharmacotherapy specialist. A graduate from the University of Illinois Chicago College of Pharmacy, she completed her pharmacy practice residency program at Maricopa Medical Center in Phoenix, Arizona, a Level 1 trauma facility. In addition, she serves as a clinical instructor in emergency medicine for Midwestern University College of Pharmacy – Glendale, the University of Arizona, and Roseman University. She also provides education to the West Valley Prehospital (EMS) Group. She also serves as a member of the ASHP Preceptor Skills Section Advisory Group and American College of Clinical Pharmacy’s Emergency Medicine PRN group and has given presentations on emergency medicine topics at local and national meetings. Her professional interests include emergency/disaster management, toxicology including drugs of abuse, and infectious diseases. She is one of the three Arizona representatives to the ASHP House of Delegates.
Mindy (Throm) Burnworth  picture

Mindy (Throm) Burnworth , PharmD, BCPS, FAzPA
Associate Professor, Midwestern University College of Pharmacy-Glendale


Brief Bio : Melinda (Throm) Burnworth, PharmD, FASHP, FAzPA, BCPS; Professor of Pharmacy Practice: Dr. Burnworth graduated from the University of Missouri Kansas City School of Pharmacy in 2001. She then completed ASHP-accredited residencies in Pharmacy Practice (PGY1) and Adult Internal Medicine (PGY2) at Grady Health System in Atlanta, Georgia. She joined the faculty at Midwestern in 2004. Burnworth precepts pharmacy students on advanced pharmacy practice experiences at Maricopa Medical Center where she provides clinical pharmacy services for an adult internal medicine team. She is involved with teaching several hospital based courses at the University and an elective course called Rare and Interesting Diseases. She has special interests in rare diseases, efforts to minimize drug shortages, political advocacy, student mentorship, preceptor development, and women in pharmacy leadership. Burnworth is actively involved with the Arizona Pharmacy Association (AzPA) Health-System Academy and the American Society of Health-System Pharmacists (ASHP).
Renee Tyree picture

Renee Tyree, PharmD, MHA
Director of Pharmacy, HealthSouth Rehabilitation Hospital


Brief Bio : Dr. Tyree earned her PharmD from the University of Arizona and her Masters of Health Administration from the University of Cincinnati. Renee In her role as West Regional Pharmacy Director for Encompass Health, (formerly HealthSouth), Renee provides clinical and operational leadership for 16 rehabilitation hospitals. Her particular areas of interest are in medication management in physical medicine, including spinal cord dysfunction, Stroke and Parkinson’s disease. Renee continues to write and present locally and nationally on various topics of medication use in the practice of physical medicine and rehabilitation including stroke, hip fracture and medication and driving. She is actively involved with the Academy of Spinal Cord Injury Professionals (ASCIP) and the newly formed American Congress of Rehabilitation Medicine Pharmacy Task Force.

Activity Number

0100-0000-18-002-L04-P/T
Date: 04/28/18
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

The Role of Biosimilars for Pharmacy:  Applications for Biosimilars for Pharmacy and the Pharmacist
 
 Pharmacist learning objectives:
At the completion of this activity, the participant will be able to:
1.  Review clinical trial design, regulatory approval pathways, and extrapolation of indications.
2.  Describe the safety and efficacy of biosimilars in rheumatologic, oncology and nephrology indications.
3.  Recognize clinical considerations, including immunogenicity, switching, and interchangeability with biosimilars.
4.  Address implications for reimbursement with biosimilars with state and federal regulatory concerns. 
 
Pharmacy Technician learning objectives:
At the completion of this activity, the participant will be able to:
1.  Review clinical trial design, regulatory approval pathways for biosimilars.
2.  Describe the safety and efficacy of biosimilars in reheumatologic, oncology and nephrology.
3.  Address implications for reimbursement with biosimilars with state and federal regulatory concerns. 

Speaker(s)/Author(s)

Ali McBride picture

Ali McBride, PharmD, MS, BCPS
Clinical Coordinator of Hematology/Oncology, University of Arizona Cancer Center


Brief Bio : Ali McBride, PharmD., MS, BCPS, is the Clinical Coordinator of Hematology/Oncology at The University of Arizona Cancer Center and the Director of Supportive Oncology Research Trials at The University of Arizona Cancer Center. He currently serves as Secretary of the Association of Community Cancer Centers (ACCC) and he has been actively involved with the American Society of Health-System Pharmacy (ASHP) currently serving as the Chair for the SAG on Emerging Sciences and serves on the AzPA legislative affairs committee.

Activity Number

0100-0000-17-070-L01-P/T
Date: 04/28/18
Time: 01:30 PM - 02:30 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Critical Controversies Within Critical Care
 
Pharmacist learning objectives:
At the completion of this activity, the participant will be able to:
1. Recognize the literature behind recommendations for anticoagulation in septic emboli.
2. Describe the appropriate use of etomidate in RSI.
3. Justify why intermittent PPIs are commonly used for GI bleeding rather than continuous infusion.
 
Pharmacy Technician learning objectives:
At the completion of this activity, the participant will be able to:
1. Recognize pharmacologic agents used for anticoagulation in septic emboli.
2. Describe the role of induction agents in rapid sequence intubation (RSI).
3. Describe the use of proton pump inhibitors in an acute GI bleed.

Speaker(s)/Author(s)

Lauren Fruhling, PharmD.
PGY-2 Critical Care Resident, Banner University MC


Brief Bio : Lauren Fruhling is a current PGY-2 Critical Care Pharmacy Resident at University of Arizona College of Pharmacy. Lauren went to Virginia Commonwealth University for pharmacy school and completed her PGY-1 Residency at University of Arizona.

Michelle LaFever, PharmD.
PGY-2 Critical Care Resident, Banner University MC


Brief Bio : Michelle went to University of Iowa for pharmacy school and completed her PGY-1 Residency at University of Arizona.

Shannon Sullivan , PharmD.
PGY-2 Emergency Medicine Resident, Banner University MC


Brief Bio : Shannon Sullivan is the current PGY-2 Emergency Medicine Pharmacy Resident at University of Arizona College of Pharmacy. Shannon attended University of Southern California for pharmacy school and completed her PGY-1 Residency at Lawrence Memorial Hospital.

Activity Number

0100-0000-17-072-L01-P/T
Date: 04/28/18
Time: 02:45 PM - 03:45 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Pipeline Products:  Are opioids the answer for treatment-refractory depression?
 
Pharmacist learning objectives:
At the completion of this activity, the participant will be able to: 
1.  Explain the pathophysiology of depression and describe how the opioid pathway may be a key player.
2.  Describe the mechanism of action of the pipeline combination product buprenorphine/samidorphan.
3.  Evaluate results of FORWARD trials and interpret in light of practice implications.
 
Pharmacy Technician learning objectives:
At the completion of this activity, the participant will be able to: 
1.  List and classify the two components of combination product buprenorphine/samidorphan.
2.  State potential uses and dosing regimen of buprenorphine/samidorphan.
3.  Predict likelihood of scheduling status and interpret impact on pharmacies.
 

Speaker(s)/Author(s)

Alyssa Peckham picture

Alyssa Peckham, PharmD., BCPP
Associate Professor, Midwestern University College of Pharmacy-Glendale

Activity Number

0100-0000-17-073-L01-P/T
Date: 04/28/18
Time: 02:45 PM - 03:45 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

"Is it me or is there an interaction between us?"  Drug Interactions in Psychiatry
 
Pharmacist learning objectives
1.  Describe the different types of drug interactions and related pathophysiology.
2.  Identify common drug interactions within the antidepressant, antipsychotic, and antiepileptic classes.
3.  Apply drug interaction knowledge to patient scenarios.
 
Pharmacy Technician learning objectives
1.  Describe the different types of drug interactions and related pathophysiology.
2.  List common drug interactions within the antidepressant, antipsychotic, and antiepileptic classes.
3.  Identify potential drug interactions in a given patient scenario.

Speaker(s)/Author(s)

Ivana Bogdanich picture

Ivana Bogdanich, PharmD.
PGY-2 Internal Medicine Resident, Banner University MC


Brief Bio : Ivana Bogdanich, PharmD, received her Bachelor's in Biology from the University of Texas at Austin. She received her Doctor of Pharmacy from Texas Tech University, and completed her PGY1 pharmacy residency at the University of Iowa. She will be completing her PGY2 internal medicine pharmacy residency at Banner – University Medical Center Tucson. Her areas of interest include patient safety, cardiology, infectious diseases, and internal medicine.

Activity Number

0100-0000-18-001-L01-P/T
Date: 04/28/18
Time: 02:45 PM - 03:45 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Matters of the Heart:  Review of Guidelines for Primary Prevention of Cardiovascular Disease
 
Pharmacist learning objectives:
At the completion of this activity, the participant will be able to:
1.  Differentiate between appropriate blood pressure goals based on available hypertension guidelines.
2.  Select appropriate antihypertensive therapy based on patient-specific factors.
3.  Describe the role of statin intensity and non-statin therapy in the management of dyslipidemia.
4.  Identify guideline-directed lifestyle modifications that can reduce cardiovascular risk.
 
Pharmacy Technician learning objectives:
At the completion of this activity, the participant will be able to:
1.  Recognize different blood pressure goals based on available hypertension guidelines.
2.  Describe available antihypertensive therapy.
3.  Describe statin and non-statin therapy used in the management of hyperlipidemia.
4.  Name 3 guideline-direct lifestyle modifications that can reduce cardiovascular risk.
 

Speaker(s)/Author(s)

Kimberly Langley picture

Kimberly Langley, PharmD., MBA, BCPS
Clinical Pharmacist, Indian Health Services


Brief Bio : LCDR Kimberly Andrews is a pharmacist with the Indian Health Service (IHS). Her current duty station is the Phoenix Indian Medical Center in Phoenix, AZ. LCDR Andrews received her Doctorate of Pharmacy degree from Medical University of South Carolina (Charleston, SC). She also concurrently earned her Master of Business Administration degree from The Citadel (Charleston, SC). LCDR Andrews is also a Board Certified Pharmacist in Pharmacotherapy. Upon graduating from pharmacy school, she completed an IHS PGY-1 pharmacy residency at the Phoenix Indian Medical Center (PIMC) where she became a credentialed provider for many of the hospital’s pharmacy-based clinics including anticoagulation, latent tuberculosis, and immunizations. To improve access to care and clinical outcomes, LCDR co-established a cardiovascular risk reduction clinic managing hypertension and hyperlipidemia as her residency project. After completion of her residency, LCDR Andrews accepted a position as the pharmacy manager at the Santo Domingo Health Center (now known as the Kewa Pueblo Health Center) in Santo Domingo, NM. LCDR Andrews later moved to the Santa Fe Indian Hospital where she served as a clinical pharmacist in the anticoagulation clinic. She continued her involvement with the PGY-1 residency program at Santa Fe Indian Hospital by serving as the direct patient care preceptor for the program. She later returned back to the Phoenix Indian Medical Center in 2012 as a clinical pharmacist working in the acute care and ambulatory care setting including the hospital’s pharmacy-based clinics and sought to revitalize services in the Cardiovascular Risk Reduction Clinic, now serving as Clinic Co-Director. She also took on the responsibility as Residency Program Director for the PGY-1 program.
MaryJo Zunic picture

MaryJo Zunic, PharmD, MHA, BCACP, PhC
Pharmacist Clinician, Indian Health Services


Brief Bio : Dr. Zunic graduated from the University of Arizona in 2000 and completed a general pharmacy practice residency at Phoenix Indian Medical Center in 2001. She has continued to develop her clinical skills by completing certificate courses in diabetes, lipid management, hypertension, anticoagulation and immunization prescribing. She earned her BCPS in 2007 and since then has earned her BCACP in 2015. Her pharmacist clinician license was granted in 2005 from the state of New Mexico. Most of her practice has varied from working in the outpatient pharmacy environment at various Indian Health Service sites to also supervising and working as a Pharmacist Clinician within the Healthy Heart Project at Albuquerque Indian Health Center. She now works full time on a patient care team within the Albuquerque Indian Health Service as a pharmacist clinician. In addition to her clinical skills development, she has taken leadership courses with ASHP and completed her MHA with Simmons College in 2013. She was tasked by her clinic to work as a Quality and Performance Improvement officer in 2012, on a one-year assignment to get the organization ready for the AAAHC re-accreditation cycle. She serves in various leadership capacities within her clinic and also nationally on the PHS Pharmacy Professional Advisory Committee. Dr. Zunic enjoys teaching and has done presentations at the National Arizona Pharmacy Association meetings on diabetes care and also within the Indian Health Service Southwest Regional Pharmacy Continuing Education Meeting on various topics such as diabetes care, vitamin D, lipid management, and utilizing quality and performance improvement tools to advance your practice. She has also served as faculty with the Pharmacy Practice Training Program within the Indian Health Service for 8 years now.

Activity Number

0100-0000-17-071-L01-P/T
Date: 04/28/18
Time: 04:00 PM - 05:30 PM

CE Hours

1.50
Registration Closed  

Registration Closed  

To PrEP or not to PrEP:  PreExposure Prophylaxis for HIV
 
Pharmacist learning objectives:
At the completion of this activity, the participant will be able to:
1.  Summarize the evidence supporting Pre-Exposure Prophylaxis for HIV (PrEP) use in different patient populations based on efficacy, risks and benefits.
2.  Describe factors used to determine candidates for PrEP.
3.  Identify key counseling points for patients initiating PrEP.
4.  Discuss future directions of PrEP.
 
Pharmacy Technician learning objectives:
At the completion of this activity, the participant will be able to:
1.  List factors used to determine candidates for Pre-Exposure Prophylaxis for HIV (PrEP).
2.  Identify key counseling points for patients initiating PrEP.
4.  Discuss future directions of PrEP.

Speaker(s)/Author(s)

George Nawas picture

George Nawas, PharmD, BCPS
Banner University Medical Center


Brief Bio : George Nawas, PharmD, BCPS, received both his Bachelor's in Pharmaceutical Sciences and his Doctor of Pharmacy from the Lebanese American University. He completed his PGY1 pharmacy residency at Banner – University Medical Center Tucson and will be completing his PGY2 internal medicine pharmacy residency also at Banner – University Medical Center Tucson. His areas of interest include internal medicine, infectious diseases/HIV, emergency medicine, and academia.

Activity Number

0100-0000-18-003-H02-P/T
Date: 04/28/18
Time: 04:00 PM - 05:00 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Improving Continuum of Care Post Hospital Discharge with Medication Therapy Management
 
Pharmacist learning objectives:
At the completion of this activity, the participant will be able to: 
1.  Describe the global trends in hospital readmissions related to specific conditions. 
2.  Apply best practice measures when assessing, evaluating, and developing a clinical action plan for patients in an effort to prevent hospital readmission. 
3.  Identify the importance of interprofessional teams 
4.  Apply best practice methods related to medication therapy management in order to enhance the patient's continuum of care beyond the transition of care period. 

Pharmacy Technician learning objectives
At the completion of this activity, the participant will be able to: 
1.  Describe the global trends in hospital readmissions related to specific conditions. 
2.  Identify the importance of interprofessional teams. 
3.  Apply best practice methods related to medication therapy management in order to enhance the patient's continuum of care beyond the transition of care period.

Speaker(s)/Author(s)

Jennifer Bingham picture

Jennifer Bingham, PharmD.
TOC Coordinator, PGY-2 Residency Preceptor , University of Arizona Medication Management Center


Brief Bio : Dr. Jenny Bingham is a graduate of the University of Arizona. Dr. Bingham served as both the Transition of Care Program Coordinator (2012-2017) and Pharmacogenomics Program Coordinator (2012-2013) at the Medication Management Center at the University of Arizona, as well as a clinical pharmacist at a rural hospital (2010-2013). Her role in the development of novel telehealth models has led to the success of nationally-recognized innovative programs. She continues to support clinical program innovation as a Clinical Pharmacy Specialist at SinfoníaRx. Dr. Bingham also serves as the PGY2 Ambulatory Care residency preceptor and offers electives in care transitions and neurotelehealth. She has spoken at national and international forums on efforts to integrate telehealth pharmacists into chronic care management, transitions-of-care, and epilepsy medication management with the aim to improve patient care. Dr. Bingham is a proud recipient of the Exemplary Patient Care Award from the Arizona Pharmacy Association. She advocates involvement within her professional community and serves as the Chair of the American Pharmacists Association's Medication Therapy Management Telehealth Committee, Chair for the Arizona Pharmacy Association’s Mentor Connection Program, and serves as a Clinical Instructor in Pharmacy Practice & Science at the University of Arizona College of Pharmacy, University of Florida, and the St. Louis College of Pharmacy.
Jessica DiLeo picture

Jessica DiLeo, PharmD, BCACP, BCGP
Medication Management Specialist, Medication Management Center


Brief Bio : Dr. Jessica DiLeo has over 16 years experience in the pharmacy profession working as a technician, intern, and pharmacist in a variety of settings such as managed care, health systems, and community. Since graduating from the University of Arizona, her career focuses on geriatric and ambulatory care at the University of Arizona Medication Management Center. She serves as the Center’s Clinical Trainer, Recruitment Coordinator, and Residency and Education Coordinator. She has been an active member of the Arizona Pharmacy Association (AzPA) since 2010 and currently serves as President-Elect. With five years experience on the AzPA Board of Directors, she has worked closely and developed relationships with the CEO, Executive Board of Directors, Board of Directors, and staff. Additionally, she maintains a close relationship with her Alma mater where she frequently guest lectures and serves as the Faculty Advisor for Student Pharmacist Academy.

Activity Number

0100-0000-17-067-L04-P/T
Date: 04/28/18
Time: 04:00 PM - 05:00 PM

CE Hours

1.00
Registration Closed  

Registration closes on Apr 30, 2018 at 05:00 PM

Registration Closed  

Pharmacy Law Update 2018
 
Learning Objectives
At the completion of this activity, the participant will be able to: 
1.  Identify major developments in U.S. Pharmacy law and related fields.
2.  Describe the practical ramifications of proposed state and national legislative initiatives.
3.  Recognize emerging patterns that will broadly affect the healthcare profession and pharmacy practice. 

Speaker(s)/Author(s)

Roger Morris picture

Roger Morris, RPh, J.D.
National Chair, Health and Life Sciences Industry Team, Quarles & Brady, LLP


Brief Bio : Roger Morris, RPh., J.D., is the national chair of Quarles & Brady's Health & Life Sciences Industry Team, former chair of the firm's Health Law Practice Group, and a member of the firm's governing Executive Committee. His practice focuses on the representation of pharmacies, including retail pharmacies, pharmacy wholesalers, specialty pharmacies, compounding pharmacies, mail order pharmacies, veterinary pharmacies, pharmacy benefit managers (PBMs), and pharmacy manufacturers. He also represents health care providers, including hospitals, health systems, and medical staff. Roger's previous career as a pharmacist enables him to provide unique insight to clients on a wide range of issues, including licensing new pharmacy locations, responding to regulatory inquiries and investigations before state review boards, and the development of complex new programs that include multiple points in the pharmacy distribution process and multi-state jurisdictional matters.

Activity Number

0100-0000-18-004-L03-P/T
Date: 04/29/18
Time: 08:00 AM - 09:30 AM

CE Hours

1.50
Registration Closed  

Registration Closed  

Should Clinical Indication Be Required on Prescriptions?
 
Pharmacist learning objectives:
At the completion of this activity, the participant will be able to:
1.  Discuss what information pharmacists need to do their jobs.
2.  Review the current requirements for prescriptions in the state of Arizona.
3.  Recognize how patient care is optimized when pharmacists have access to indication or diagnosis on prescriptions.
4.  Discuss the pros and cons of requiring indication or diagnosis on prescriptions.
 
Pharmacy Technician learning objectives:
At the completion of this activity, the participant will be able to:
1.  Discuss what information pharmacists need to do their jobs.
2.  Review the current requirements for prescriptions in the state of Arizona.
3.  Recognize the importance of patient care when pharmacists have access to indication or diagnosis on prescriptions.
 
 

Speaker(s)/Author(s)

Joseph Murata, PharmD-Candidate 2019 picture

Joseph Murata, PharmD-Candidate 2019, B.S.
University of Arizona College of Pharmacy


Brief Bio : PharmD Candidate 2019, is a pharmacy student at the University of Arizona College of Pharmacy in Tucson. He received his Bachelor’s in Nutritional Sciences from the University of Arizona. He plans to pursue a PGY1 pharmacy residency after graduating. His areas of interest include internal medicine, critical care, and transitions of care.
Michael Rupp picture

Michael Rupp, BS Pharm., PhD, FAPhA
Professor of Pharmacy Administration, Midwestern University College of Pharmacy-Glendale


Brief Bio : Dr. Rupp earned his B.S. in pharmacy from the University of Kansas and his Ph.D. in pharmaceutical administration and health policy from The Ohio State University. He has practiced pharmacy in both community and institutional settings including serving as a commissioned officer in the U.S. Public Health Service with the Navajo Indian tribe of New Mexico and Arizona. In 1999, following twelve years on the faculty at Purdue University, he joined the faculty of Midwestern University in Glendale, Arizona, where he currently serves as Professor of Pharmacy Administration. Dr. Rupp's academic career has emphasized the study of contemporary issues in pharmacy practice. He has been particularly active in evaluating the cost and effectiveness of pharmacist care services and assessing the quality and safety of supportive technologies such as electronic prescribing and computer-assisted DUR in pharmacy practice.
Terri Warholak picture

Terri Warholak, RPh, PhD, FAPhA, CPHQ
Professor, University of Arizona College of Pharmacy


Brief Bio : Terri Warholak is a Professor in the Department of Pharmacy Practice and Science at the University of Arizona College of Pharmacy, Tucson and serves as the director of the Health Outcomes & PharmacoEconomics Center Research Team for the University of Arizona Medication Management Center and SinfoníaRx. She received her BS, MS, and PhD from Purdue University. From 1990 to 1997, Dr. Warholak served as a Commissioned Officer in the United States Public Health Service where her clinical pharmacy experience spanned from inpatient to community practice and included 5 years in the Indian Health Service and an assignment at the Food and Drug Administration (FDA). In 2015, Dr. Warholak and colleagues were recognized as winner of Academy for Healthcare Improvement Duncan Neuhauser Award for Curricular Innovation for the Educating Pharmacists in Quality (EPIQ) program, which is available as open source educational materials on the Pharmacy Quality Alliance (PQA) website. She serves on many national committees including: the Food and Drug Administration (FDA) Drug Safety and Risk Management Advisory Committee (DSaRM) since 2016; the US Pharmacopeial Convention Healthcare Quality Expert Committee since 2015; and the PQA Research Coordinating Committee. Her teaching and research interests include medication error reduction, health information technology, and measure development. She has edited a book, published over 80 papers and has been invited to present at the local, state, and national levels.

Activity Number

0100-0000-18-005-L04-P/T
Date: 04/29/18
Time: 09:45 AM - 11:15 AM

CE Hours

1.50
Registration Closed  

Registration Closed  

2018 New Drug Update
 
Pharmacist learning objectives:
At the completion of this activity, the participant will be able to:
1.  Compare and contrast the benefits and risks of recently FDA approved drugs versus older drugs. 
2.  Identify new therapeutic options for conditions with inadequate or no previous drug therapy options.
3.  Identify potential severe and or life-threatening adverse drug reactions associated with newly approved drugs.
 
Pharmacy Technician learning objectives:
At the completion of this activity, the participant will be able to:
1.  Alert pharmacists and interns of gaps in order for necessary pre-treatment prophylactic medications for newly approved drugs.
2.  Identify when patients have completed required testing prior to initiation of select new drug therapies.
3.  Correctly locate information on the complex preparation of infused medications.

Speaker(s)/Author(s)

Robert J. Lipsy picture

Robert J. Lipsy, PharmD, BCACP, FASHP, FAzPA
Medication Management Specialist, Sinfonia RX-Medication Management Center


Brief Bio : Robert Lipsy, PharmD, FASHP, BCPS, is currently the Senior Clinical Pharmacist and Medication Management Specialist, at the Medication Management Center, College of Pharmacy, University of Arizona. He is also an Assistant Professor at the College. Dr. Lipsy has over 35 years of clinical pharmacy experience. Prior to joining the medication management center, Dr. Lipsy served in clinical roles in academic, hospital, and managed care pharmacy. He is a fellow of the American Society of Health-System Pharmacists and in 2001, was awarded the Elias Schlossberg Lifetime Achievement Award by the Arizona Society of Health-System Pharmacists. Dr. Lipsy is also a fellow of the Arizona Pharmacy Association and a member of the association’s Hall of Fame. Dr. Lipsy has authored numerous articles, books and book chapters and given over 100 local, regional, and national presentations and lectures.

Activity Number

0100-0000-18-006-L04-P/T
Date: 04/29/18
Time: 11:30 AM - 12:30 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Release Date: Apr 28, 2018
Credit Expiration Date: May 30, 2018

Registration Closed